Journal of Cancer Research Reviews & Reports

Breast cancer patients must have a triple evaluation that includes clinical assessment, imaging, and tissue biopsy. When tumors lack estrogen, progesterone, and ERBB2 receptors, preoperative chemotherapy is the only choice and may even be utilized. If the tumor can be entirely removed with favorable cosmetic outcomes, a lumpectomy with radiation therapy or a mastectomy are the two alternatives for the surgical phase. The present study was a retrospective study that included a review of the medical records of female patients who visited the oncology department in a tertiary hospital in Egypt to describe breast cancer treatment patterns among these patients. The study included 150 patients, the age of more than 50% of them was more than 49 years (57.3) and about 33% of them had a family history of cancer. Only 14% of the patients had metastatic cancer and 50% of them had chronic diseases. More than 61% of the patients had breast surgeries. The most used surgery was breast-conserving surgery (60.9%). The most prescribed chemotherapeutic agents for breast cancer patients were cyclophosphamide (96.4%), doxorubicin (54.5%), docetaxel (54.5%), fluorouracil (10.9%), epirubicin (10.9%), and paclitaxel (10.9%). For patients with breast cancer, drug monitoring is crucial for confirming the potency and quality of the medications they are prescribed. The use of pharmaceuticals should be examined on a regular basis and should be in line with evidence-based practices.